Hitalada, Baby Boy .
HRN: 25-08-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/26/2024
07/03/2024
IV
35mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes